Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial (2018)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00125-018-4619-x
PubMed Identifier: 29728717
Publication URI: http://europepmc.org/abstract/MED/29728717
Type: Journal Article/Review
Parent Publication: Diabetologia
Issue: 7
ISSN: 0012-186X